 LA JOLLA, Calif.--BUSINESS WIRE--DermTech, Inc. NASDAQ: DMTK DermTech, a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today that SKIN has published the results of a large registry study finding that the evaluation of genomic atypia using DermTechs Pigmented Lesion Assay the PLA may be a superior approach to guide treatment decisions and manage pigmented lesions, when compared to visual assessment of pigmented lesions. Melanoma is a lif 